Core Laboratories Inc. (CLB) is a publicly traded Energy sector company. As of May 21, 2026, CLB trades at $13.77 with a market cap of $625.07M and a P/E ratio of 21.87. CLB moved +0.00% today. Year to date, CLB is -24.16%; over the trailing twelve months it is +20.09%. Its 52-week range spans $9.72 to $21.83. Rallies surfaces CLB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Core Laboratories Q1 Revenue $121.8M, GAAP Loss $0.02, Ex-Items EPS $0.06: Core Laboratories reported Q1 revenue of $121.8 million, down 12% sequentially and flat year-over-year, with a GAAP loss of $0.02 per share and adjusted EPS of $0.06. Operating income totaled $1.9M GAAP and $6.6M ex-items, net debt rose $3.9M and the company repurchased 51,781 shares for $0.9M.
| Metric | Value |
|---|---|
| Price | $13.77 |
| Market Cap | $625.07M |
| P/E Ratio | 21.87 |
| EPS | $0.63 |
| Dividend Yield | 0.01% |
| 52-Week High | $21.83 |
| 52-Week Low | $9.72 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $524.73M |
| Net Income | $29.57M |
| Gross Margin | 19.92% |
CLB analyst coverage data. Average price target: $0.00.